Chemical Component Summary

Namealisertib
Identifiers4-[[9-chloranyl-7-(2-fluoranyl-6-methoxy-phenyl)-5~{H}-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy-benzoic acid
FormulaC27 H20 Cl F N4 O4
Molecular Weight518.924
TypeNON-POLYMER
Isomeric SMILESCOc1cccc(c1C2=NCc3cnc(nc3-c4c2cc(cc4)Cl)Nc5ccc(c(c5)OC)C(=O)O)F
InChIInChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)
InChIKeyZLHFILGSQDJULK-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count57
Chiral Atom Count0
Bond Count61
Aromatic Bond Count24

Drug Info: DrugBank

DrugBank IDDB05220 
NameAlisertib
Groups investigational
DescriptionAlisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer.
Synonyms
  • Alisertib
  • Alisertib sodium
IndicationFor the treatment of various forms of cancer.
CategoriesProtein Kinase Inhibitors
CAS number1028486-01-2

Drug Targets

NameTarget SequencePharmacological ActionActions
Aurora kinase AMDRSKENCISGPVKATAPVGGPKRVLVTQQFPCQNPLPVNSGQAQRVLCP...unknowninhibitor,regulator
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL483158
PubChem 24771867
ChEMBL CHEMBL483158
ChEBI CHEBI:125628